These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 26169513)
1. Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program. Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H Am J Gastroenterol; 2015 Dec; 110(12):1640-6. PubMed ID: 26169513 [TBL] [Abstract][Full Text] [Related]
2. Colon Cancer Screening - Is It Time Yet? Bhurgri H; Samiullah S J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518 [TBL] [Abstract][Full Text] [Related]
3. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba. Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517 [TBL] [Abstract][Full Text] [Related]
4. Trends in colorectal cancer testing among Medicare subpopulations. Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761 [TBL] [Abstract][Full Text] [Related]
5. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337 [TBL] [Abstract][Full Text] [Related]
6. Trends in colorectal cancer test use among vulnerable populations in the United States. Klabunde CN; Cronin KA; Breen N; Waldron WR; Ambs AH; Nadel MR Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1611-21. PubMed ID: 21653643 [TBL] [Abstract][Full Text] [Related]
7. Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening. Decker KM; Lambert P; Nugent Z; Biswanger N; Samadder J; Singh H JAMA Netw Open; 2020 May; 3(5):e205741. PubMed ID: 32453385 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Sharaf RN; Ladabaum U Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579 [TBL] [Abstract][Full Text] [Related]
9. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province. Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Tsoi KK; Ng SS; Leung MC; Sung JJ Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138 [TBL] [Abstract][Full Text] [Related]
12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Wee CC; McCarthy EP; Phillips RS Prev Med; 2005 Jul; 41(1):23-9. PubMed ID: 15916989 [TBL] [Abstract][Full Text] [Related]
14. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097 [TBL] [Abstract][Full Text] [Related]
15. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba. Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176 [TBL] [Abstract][Full Text] [Related]
16. Vital signs: colorectal cancer screening test use--United States, 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(44):881-8. PubMed ID: 24196665 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer test use--Maryland, 2002-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446 [TBL] [Abstract][Full Text] [Related]
18. Sex-based disparities in colorectal cancer screening. Yager SS; Chen L; Cheung WY Am J Clin Oncol; 2014 Dec; 37(6):555-60. PubMed ID: 23466582 [TBL] [Abstract][Full Text] [Related]
19. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. Choi KS; Lee HY; Jun JK; Shin A; Park EC J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224 [TBL] [Abstract][Full Text] [Related]
20. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program. Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]